ArriVent BioPharma (AVBP) EPS (Basic) (2023 - 2026)
ArriVent BioPharma (AVBP) posted EPS (Basic) of -$0.96 for Q1 2026, down 4.01% sequentially from -$0.92 in Q4 2025, and up 49.39% YoY from -$0.64 in Q1 2025.
ArriVent BioPharma (AVBP) EPS (Basic) (2023 - 2026) Analysis & Trends
ArriVent BioPharma has reported EPS (Basic) for 4 years, with the latest figure at -$0.96 in Q1 2026.
- Quarterly EPS (Basic) rose 49.39% year-over-year to -$0.96 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.22 (up 14.29% YoY) and the FY2025 annual result came in at -$4.32, down 69.06% from the prior year.
- EPS (Basic) retreated to -$0.96 in Q1 2026 per AVBP's latest filing, from -$0.92 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.61 in Q3 2024 and troughed at -$10.79 in Q2 2023.
- A 4-year average of -$3.37 and a median of -$0.92 in 2025 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) jumped 93.95% in 2024, then plunged 173.14% in 2025.
- Over 4 years, EPS (Basic) stood at -$9.9 in 2023, then soared by 93.38% to -$0.66 in 2024, then slumped by 40.95% to -$0.92 in 2025, then dropped by 4.01% to -$0.96 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.96, -$0.92, and -$0.83 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | ArriVent BioPharma | 1.43 Bn | 1.43 Bn | - | -1.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.11 |
| Mar 31, 2026 | -0.96 |
| Dec 31, 2025 | -0.92 |
| Sep 30, 2025 | -0.83 |
| Jun 30, 2025 | -0.90 |
| Mar 31, 2025 | -1.90 |
| Dec 31, 2024 | -0.66 |
| Sep 30, 2024 | -0.61 |
| Jun 30, 2024 | -0.65 |
| Mar 31, 2024 | -0.70 |
| Dec 31, 2023 | -9.90 |
| Sep 30, 2023 | -5.52 |
| Jun 30, 2023 | -10.79 |
| Mar 31, 2023 | -9.45 |